PETER HU: Open Payments
NPI 1194066266 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 122 payments from 15 companies in 2025. Trend: 2023 $1,289 · 2024 $1,074 · 2025 $2,355
Food & beverage: $2,255Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 28 | $370 |
| Arcutis Biotherapeutics, Inc. | 24 | $315 |
| Regeneron Healthcare Solutions, Inc. | 10 | $305 |
| LEO Pharma Inc. | 20 | $275 |
| Amgen Inc. | 8 | $222 |
| GENZYME CORPORATION | 7 | $216 |
| Janssen Biotech, Inc. | 4 | $140 |
| Organon LLC | 4 | $87 |
| UCB, Inc. | 4 | $85 |
| ABBVIE INC. | 3 | $82 |
Products named: DUPIXENT, OPZELURA, Zoryve, OTEZLA, ADBRY, TREMFYA, Bimzelx, SKYRIZI.
Industry payments across NY — which companies pay providers there.
